回到顶部
2019 - 03 28

The 2nd Symposium on Biochemical Drug Innovation and Development

date: 2019-03-28
Views: 5

On August 11, 2018, the 'Second Symposium on Biochemical Drug Innovation and Development' sponsored by China Biochemical Pharmaceutical Industry Association and the second academician public welfare lecture hall of the National Pharmacopoeia Commission were successfully held in Hebei Zhangzhou International Conference Center. As the co-organizer, Zhejiang Huashang Pharmaceutical Group hosted a sub-venue named after the group and was presided over by Zhou Tianqiong, deputy general manager of the group.


The speakers of the seminar invited dozens of experts such as Academician Wang Guangji of the Chinese Academy of Engineering and Academician Shen Beifen of the Military Medical Research Institute, and attracted more than 500 experts and scholars, pharmaceutical industry researchers and pharmaceutical companies from all over the country to participate. The main contents of the seminar include policy development trend, quality standard improvement, production management compliance, original and auxiliary package related approval, interpretation of the listing permit holder system, consistency evaluation and re-evaluation. Through this activity, the government management department was promoted. The industry's authoritative experts and peer companies' dialogue and information sharing, while providing biochemical companies with a platform for communication and learning.


The China Biochemical Pharmaceutical Industry Association was commissioned by the former State Food and Drug Administration's Pharmacology Supervision Department to organize relevant experts and related enterprises to draft the “Biochemical GMP Appendices”, which was promulgated on March 16, 2017 and implemented on September 1. At the summit seminar, China Biochemical Pharmaceutical Industry Association issued a certificate to the drafting experts of the “Biochemical GMP Appendices” and the drafting units, and Zhejiang Huaduan Pharmaceutical Group as the drafting unit, and obtained the “Biochemical GMP Appendix to participate in the drafting unit”. certificate.

浙江华缔药业集团助力中国生化制药工业协会协办“第二届生化药物创新与发展高峰研讨会”并获得“生化药GMP附录参与起草单位”证书


发布时间: 2019 - 03 - 28
文件大小:
发布时间: 2019 - 05 - 02
文件大小:
发布时间: 2019 - 05 - 01
文件大小:
发布时间: 2019 - 05 - 01
文件大小:
News & Events / 热点新闻
2019 - 03 - 11
点击次数: 66
Spring breeze, the flowers are fragrant. On the afternoon of March 8, on the occasion of the “March 8 International Women's Day”, Hualian Group launched the “Elegant Woman, Wonderful Life” theme tea c...
2019 - 03 - 28
点击次数: 14
On January 4th, Chen Zhihui, deputy director of the Zhejiang Provincial Drug Administration, went to Anji to carry out the “three services” activities, and went deep into the bio-pharmaceutical compan...
2019 - 03 - 28
点击次数: 6
On the morning of September 8, 2018, deputy secretary of Huzhou Municipal Committee, Mayor Qian Sanxiong, deputy mayor Xiang Lemin, city government secretary Xu Yuping, deputy secretary general He Yua...
2019 - 03 - 28
点击次数: 5
On August 11, 2018, the 'Second Symposium on Biochemical Drug Innovation and Development' sponsored by China Biochemical Pharmaceutical Industry Association and the second academician public welfare l...

News & Events

Communicate one step closer
0571-87207239
Share to the community Good website to share
Feedback Further communication
Click to send
 
Copyright © 2019 - 2022
Hangzhou Huabang Group Co., Ltd.
犀牛云提供企业云服务